PTCT Lee Scott Golden sells $634K worth of shares
Mar 10, 2026, 4:34 AM
0.00%
What does PTCT do
PTC Therapeutics, headquartered in Warren, New Jersey, develops medicines for rare disorders and has two key products for Duchenne muscular dystrophy. The company went public in 2013 and employs 988 people.
Lee Scott Golden sold 10,000 shares of PTCT on 5 March at $63.38 per share, worth a total of $634K. They now own 79,944 PTCT shares, or a 11% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.